{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:53:35Z","timestamp":1782316415889,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To assess the outcome of extracorporeal membrane oxygenation (ECMO) for severe adenovirus (Adv) pneumonia with refractory hypoxic respiratory failure (RHRF) in paediatric patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective observational study was performed in a tertiary paediatric intensive care unit (PICU) in China. Patients with RHRF caused by Adv pneumonia who received ECMO support after mechanical ventilation failed to achieve adequate oxygenation between 2017 and 2020 were included. The outcome variables were the in-hospital survival rate and the effects of ECMO on the survival rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 18 children with RHRF received ECMO. The median age was 19 (9.5, 39.8) months, and the median ECMO duration was 196 (152, 309) h. The in-hospital survival rate was 72.2% (13\/18). Thirteen patients (72.2%) required continuous renal replacement therapy (CRRT) due to fluid imbalance or acute kidney injury (AKI). At ECMO initiation, compared with survivors, nonsurvivors had a lower PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> ratio [49 (34.5, 62) vs. 63 (56, 71); <jats:italic>p<\/jats:italic> = 0.04], higher oxygen index (OI) [41 (34.5, 62) vs. 30 (26.5, 35); <jats:italic>p<\/jats:italic> = 0.03], higher vasoactive inotropic score (VIS) [30 (16.3, 80) vs. 100 (60, 142.5); <jats:italic>p<\/jats:italic> = 0.04], longer duration from mechanical ventilation to ECMO support [8 (4, 14) vs. 4 (3, 5.5) h, <jats:italic>p<\/jats:italic>=0.02], and longer time from confirmed RHRF to ECMO initiation [9 (4.8, 13) vs. 5 (1.3, 5.5) h; <jats:italic>p<\/jats:italic> = 0.004]. Patients with PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> &lt;61 mmHg or an OI &gt;43 and hypoxic respiratory failure for more than 9 days before the initiation of ECMO had worse outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ECMO seemed to be effective, as severe paediatric Adv pneumonia patients with RHRF had a cumulative survival rate of 72.2% in our study. Our study provides insight into ECMO rescue in children with severe Adv pneumonia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03197-2","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T05:02:54Z","timestamp":1647406974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Extracorporeal membrane oxygenation for paediatric refractory hypoxic respiratory failure caused by adenovirus in Shanghai: a case series"],"prefix":"10.1186","volume":"22","author":[{"given":"Yun","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"3197_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1055\/s-0031-1283287","volume":"32","author":"JP Lynch 3rd","year":"2011","unstructured":"Lynch JP 3rd, Fishbein M, Echavarria M. Adenovirus. Semin Respir Crit Care Med. 2011;32:494\u2013511.","journal-title":"Semin Respir Crit Care Med."},{"key":"3197_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jcv.2012.04.018","volume":"54","author":"L Gu","year":"2012","unstructured":"Gu L, Liu Z, Li X, Qu J, Guan W, Liu Y, et al. Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing. J Clin Virol. 2012;54:295\u2013301.","journal-title":"J Clin Virol."},{"key":"3197_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0022-3468(97)90185-8","volume":"32","author":"TA Meyer","year":"1997","unstructured":"Meyer TA, Warner BW. Extracorporeal life support for the treatment of viral pneumonia: collective experience from the ELSO registry. Extracorporeal life support organization. J Pediatr Surg. 1997;32:232\u20136.","journal-title":"J Pediatr Surg."},{"key":"3197_CR4","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jpedsurg.2008.03.065","volume":"43","author":"TF Allibhai","year":"2008","unstructured":"Allibhai TF, Spinella PC, Meyer MT, Hall BH, Kofos D, DiGeronimo RJ. Survival after prolonged pediatric extracorporeal membrane oxygenation support for adenoviral pneumonia. J Pediatr Surg. 2008;43:e9\u201311.","journal-title":"J Pediatr Surg."},{"key":"3197_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MAT.0000000000000013","volume":"60","author":"P Prodhan","year":"2014","unstructured":"Prodhan P, Bhutta AT, Gossett JM, Stroud MH, Rycus PT, Bratton SL, et al. Extracorporeal membrane oxygenation support among children with adenovirus infection: a review of the extracorporeal life support organization registry. ASAIO J. 2014;60:49\u201356.","journal-title":"ASAIO J."},{"key":"3197_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/PCC.0000000000002047","volume":"20","author":"K Ramanathan","year":"2019","unstructured":"Ramanathan K, Tan CS, Rycus P, MacLaren G. Extracorporeal membrane oxygenation for severe adenoviral pneumonia in neonatal, pediatric, and adult patients. Pediatr Crit Care Med. 2019;20:1078\u201384.","journal-title":"Pediatr Crit Care Med."},{"key":"3197_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/jmv.25333","volume":"91","author":"L Xie","year":"2019","unstructured":"Xie L, Zhang B, Xiao N, Zhang F, Zhao X, Liu Q, et al. Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan. China. J Med Virol. 2019;91:392\u2013400.","journal-title":"China. J Med Virol."},{"key":"3197_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12985-019-1185-x","volume":"16","author":"LH Yao","year":"2019","unstructured":"Yao LH, Wang C, Wei TL, Wang H, Ma FL, Zheng LS. Human adenovirus among hospitalized children with respiratory tract infections in Beijing, China, 2017-2018. Virol J. 2019;16:78.","journal-title":"Virol J."},{"key":"3197_CR9","first-page":"2526","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526\u201333.","journal-title":"JAMA."},{"key":"3197_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/PCC.0000000000000350","volume":"16","author":"Pediatric Acute Lung Injury Consensus Conference Group","year":"2015","unstructured":"Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015;16:428\u201339.","journal-title":"Pediatr Crit Care Med."},{"key":"3197_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12887-020-02269-5","volume":"20","author":"J Shi","year":"2020","unstructured":"Shi J, Zhou Y, Wang F, Wang C, Miao H, Sun T, et al. A case series of children with adenovirus pneumonia: three-year experiences in a tertiary PICU. BMC Pediatr. 2020;20:375.","journal-title":"BMC Pediatr."},{"key":"3197_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fcvm.2019.00071","volume":"6","author":"A Lother","year":"2019","unstructured":"Lother A, Benk C, Staudacher DL, Supady A, Bode C, Wengenmayer T, et al. Cytokine adsorption in critically ill patients requiring ECMO support. Front Cardiovasc Med. 2019;6:71.","journal-title":"Front Cardiovasc Med."},{"key":"3197_CR13","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A Combes","year":"2018","unstructured":"Combes A, Hajage D, Capellier G, Demoule A, Lavou\u00e9 S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965\u201375.","journal-title":"N Engl J Med."},{"key":"3197_CR14","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1097\/CCM.0000000000003901","volume":"47","author":"H Miao","year":"2019","unstructured":"Miao H, Shi J, Wang C, Lu G, Zhu X, Wang Y, et al. Continuous renal replacement therapy in pediatric severe sepsis: a propensity score-matched prospective multicenter cohort study in the PICU. Crit Care Med. 2019;47:e806\u201313.","journal-title":"Crit Care Med."},{"key":"3197_CR15","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1128\/JVI.02516-12","volume":"87","author":"J Snijder","year":"2013","unstructured":"Snijder J, Reddy VS, May ER, Roos WH, Nemerow GR, Wuite GJ. Integrin and defensin modulate the mechanical properties of adenovirus. J Virol. 2013;87:2756\u201366.","journal-title":"J Virol."},{"key":"3197_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/hum.2014.001","volume":"25","author":"R Hendrickx","year":"2014","unstructured":"Hendrickx R, Stichling N, Koelen J, Kuryk L, Lipiec A, Greber UF. Innate immunity to adenovirus. Hum Gene Ther. 2014;25:265\u201384.","journal-title":"Hum Gene Ther."},{"key":"3197_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1099\/vir.0.017905-0","volume":"91","author":"W Wu","year":"2010","unstructured":"Wu W, Booth JL, Duggan ES, Patel KB, Coggeshall KM, Metcalf JP. Human lung innate immune cytokine response to adenovirus type 7. J Gen Virol. 2010;91:1155\u201363.","journal-title":"J Gen Virol."},{"key":"3197_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10096-007-0416-z","volume":"27","author":"FA Hakim","year":"2008","unstructured":"Hakim FA, Tleyjeh IM. Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature. Eur J Clin Microbiol Infect Dis. 2008;27:153\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"1036","key":"3197_CR19","first-page":"e1","volume":"125","author":"G Ferrara","year":"2012","unstructured":"Ferrara G, Zumla A, Maeurer M. Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections. Am J Med. 2012;125(1036):e1\u20138.","journal-title":"Am J Med."},{"key":"3197_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-3148.2002.00360.x","volume":"12","author":"I Krause","year":"2002","unstructured":"Krause I, Wu R, Sherer Y, Patanik M, Peter JB, Shoenfeld Y. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med. 2002;12:133\u20139.","journal-title":"Transfus Med."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03197-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03197-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03197-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T05:03:13Z","timestamp":1647406993000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03197-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3197"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03197-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shanghai Children\u2019s Hospital affiliated to Shanghai Jiao Tong University School of Medicine (2016R007-F01, 2018R52-F01, and 2020R032-F01). All the experiment protocol was in accordance to guidelines of Declaration of Helsinki in the manuscript. Informed consent was obtained from parents of all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}